Peptron, Inc. (KOSDAQ:087010)
South Korea flag South Korea · Delayed Price · Currency is KRW
232,500
+7,500 (3.33%)
May 30, 2025, 3:30 PM KST
538.67%
Market Cap 5.42T
Revenue (ttm) 4.30B
Net Income (ttm) -21.32B
Shares Out 23.30M
EPS (ttm) -994.65
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 163,435
Average Volume 228,716
Open 224,500
Previous Close 225,000
Day's Range 223,000 - 237,500
52-Week Range 34,319 - 239,000
Beta 0.78
RSI 74.35
Earnings Date n/a

About Peptron

Peptron, Inc. engages in the development of peptide-based medicines. The company’s technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. It develops PAb 001 for cancer therapy; SR-Exenatide (PT320) for Parkinson’s and other neurodegenerative disease; SR-Octreotide for the treatment of acromegaly; and Dernak filler for bioequivalence. Peptron, Inc. was founded in 1997 and is headquartered in Daejeon, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1997
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 087010
Full Company Profile

Financial Performance

In 2024, Peptron's revenue was 3.15 billion, a decrease of -5.68% compared to the previous year's 3.34 billion. Losses were -22.03 billion, 38.4% more than in 2023.

Financial Statements

News

There is no news available yet.